Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC

Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC

Background: Sorafenib is a first-line treatment option for patients with hepatocellular carcinoma (HCC). However, the impact of sorafenib resistance type on patient survival prediction and choice of second-line treatment regimen is unknown. Objectives: This study aims to explore the factors predicti...

Full description

Saved in:
Bibliographic Details
Main Authors: Jin Lei, Hongyuan Dai, Ya Zhang, Guangling Ou, Zhi Peng Liang, Yinying Lu, Haiyang Li
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359241299678
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items